Description and Brand Names
Drug information provided by: IBM Micromedex
Descriptions
Luspatercept-aamt injection is used to treat anemia in patients with beta thalassemia who need regular red blood cell (RBC) transfusions.
Luspatercept-aamt injection is also used to treat anemia in patients with myelodysplastic syndromes with ring sideroblasts (MDS-RS) or myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) who need regular red blood cell (RBC) transfusions. This medicine is given to patients who cannot receive erythropoiesis stimulating agent (ESA) or has received ESA but did not work well.
This medicine is to be given only by or under the immediate supervision of your doctor.
Portions of this document last updated: Feb. 01, 2021
Copyright © 2021 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.